Yim Sun Young相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.

通过肝细胞癌蛋白质组学分析发现，增殖和凋亡衔接蛋白 15 (PEA15) 是 VHL 和 HIF1A 的潜在致癌调节因子。

期刊:Cancer Communications

影响因子:24.9

doi:10.34133/cancomm.0020

Jeong Yun Seong, Shin Ji-Hyun, Kim Soo Mi, Sohn Bo Hwa, Yim Sun Young, Kim Ji Hoon, Shim Jae Jun, Lee Sung Hwan, Chun Yun Shin, Lee Sunyoung S, Dai Hui, Kaseb Ahmed, Kang Koo Jeong, Eltzschig Holger K, MacLeod A Robert, Luo Xiaolin, Revenko Alexey, Kim Youngsoo, Lee Ju-Seog

细胞生物学

发表日期：2026

文献求助收藏

Identifying sorafenib benefit among patients with hepatocellular carcinoma: A transcriptomic and genomic approach

利用转录组学和基因组学方法识别索拉非尼对肝细胞癌患者的获益

期刊:Jhep Reports

影响因子:7.5

doi:10.1016/j.jhepr.2026.101742

Yim, Sun Young; Kim, Hayeon; Kim, Tae Hyung; Kang, Sang-Hee; Lee, Youngwoo; Choi, Eunho; Yoo, Yang Jae; Kang, Seong Hee; Lee, Young-Sun; Jung, Young Kul; Seo, Yeon Seok; Yim, Hyung Joon; Yeon, Jong Eun; Yang, Kyung Suk; Tang, Yitao; Sohn, Bowha; Jeong, Yun Seong; Park, Hyewon; Liang, Han; Lee, Ju-Seog; Kim, Ji Hoon

细胞生物学

发表日期：2026

文献求助收藏

Correspondence to letter to the editor on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial"

致编辑的信函，主题为“基因组生物标志物预测肝细胞癌患者对阿特珠单抗联合贝伐珠单抗免疫疗法的反应：来自IMbrave150试验的启示”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.0828

Lee, Sung Hwan; Yim, Sun Young; Kim, Ji Hoon; Lee, Sunyoung S; Kaseb, Ahmed O; Wei, Peng; Lee, Ju-Seog

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Correspondence to editorial 2 on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial"

致编辑的信函，主题为“基因组生物标志物预测肝细胞癌患者对阿特珠单抗联合贝伐珠单抗免疫疗法的反应：来自IMbrave150试验的启示”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.0830

Yim, Sun Young; Lee, Sung Hwan; Kim, Ji Hoon; Lee, Sunyoung S; Kaseb, Ahmed O; Lee, Ju-Seog

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Correspondence to editorial 1 on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial"

致编辑的信函 1，主题为“基因组生物标志物预测肝细胞癌患者对阿特珠单抗联合贝伐珠单抗免疫疗法的反应：来自 IMbrave150 试验的启示”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.0829

Lee, Sung Hwan; Yim, Sun Young; Kim, Ji Hoon; Lee, Sunyoung S; Kaseb, Ahmed O; Lee, Ju-Seog

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Erratum to 'Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial' [Clin Mol Hepatol 2024;30:807-823]

对“基因组生物标志物预测肝细胞癌患者对阿特珠单抗联合贝伐珠单抗免疫疗法的反应：来自 IMbrave150 试验的见解”[Clin Mol Hepatol 2024;30:807-823]的勘误

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.0333e

Yim, Sun Young; Lee, Sung Hwan; Baek, Seung-Woo; Sohn, Bohwa; Jeong, Yun Seong; Kang, Sang-Hee; Park, Kena; Park, Hyewon; Lee, Sunyoung S; Kaseb, Ahmed O; Park, Young Nyun; Leem, Sun-Hee; Curran, Michael A; Kim, Ji Hoon; Lee, Ju-Seog

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia

亚洲自身免疫性肝炎患者肝细胞癌的发病率和危险因素

期刊:Jhep Reports

影响因子:7.5

doi:10.1016/j.jhepr.2025.101524

Yang, Jiwon; Yim, Sun Young; Kim, Kunhee; Lee, Hye Won; Choi, Jonggi

自身免疫性肝炎

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular Carcinoma

肝脏代谢特征及其与肝细胞癌免疫治疗反应的关系

期刊:ImmunoTargets and Therapy

影响因子:4.4

doi:10.2147/ITT.S491464

Park, Hyewon; Park, Sowon; Park, Kena; Yim, Sun Young; Lee, Ju-Seog; Lee, Sung Hwan

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study

SGLT2抑制剂的使用与糖尿病合并病毒性肝炎患者肝脏相关事件（包括肝细胞癌）风险降低之间的关联：一项全国性队列研究

影响因子:4.4

doi:10.3390/cancers18010120

Kang, Seong Hee; Choi, Jimi; Yim, Hyung Joon; Jung, Young Kul; Yim, Sun Young; Lee, Young-Sun; Seo, Yeon Seok; Kim, Ji Hoon; Yeon, Jong Eun; Byun, Kwan Soo

细胞生物学

发表日期：2025

文献求助收藏

Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial

利用基因组生物标志物预测肝细胞癌患者对阿特珠单抗联合贝伐珠单抗免疫疗法的反应：来自IMbrave150试验的启示

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.0333

Yim, Sun Young; Lee, Sung Hwan; Baek, Seung-Woo; Sohn, Bohwa; Jeong, Yun Seong; Kang, Sang-Hee; Park, Kena; Park, Hyewon; Lee, Sunyoung S; Kaseb, Ahmed O; Park, Young Nyun; Leem, Sun-Hee; Curran, Michael A; Kim, Ji Hoon; Lee, Ju-Seog

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏